Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapyMatthew Holderfield, Mallika Singh, Elena S. Koltun et al.|Nature|2024Cited by 319
Mechanisms of resistance to active state selective tri-complex RAS inhibitorsBen Sang, Piro Lito, Brian M. Wolpin et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 10
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapyMallika Singh, David Wildes, Matthew Holderfield et al.|Research Square|2023Cited by 5
The RAS GTPase RIT1 compromises mitotic fidelity through spindle assembly checkpoint suppressionAntonio Cuevas-Navarro, Frank McCormick|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 2
Cross-species analysis of LZTR1 loss-of-function mutants demonstrates dependency to RIT1 orthologsAntonio Cuevas-Navarro, Pau Castel|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1